These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18375481)

  • 21. High-density lipoprotein quantity or quality for cardiovascular prevention?
    Calabresi L; Gomaraschi M; Franceschini G
    Curr Pharm Des; 2010 May; 16(13):1494-503. PubMed ID: 20196739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Girona J; Masana L
    Atherosclerosis; 1998 Jun; 138(2):383-9. PubMed ID: 9690923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective uptake of high density lipoproteins cholesteryl ester in the dog, a species lacking in cholesteryl ester transfer protein activity; An in vivo approach using stable isotopes.
    Ouguerram K; Nguyen P; Krempf M; Pouteau E; Briand F; Bailhache E; Magot T
    Comp Biochem Physiol B Biochem Mol Biol; 2004 Aug; 138(4):339-45. PubMed ID: 15325333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm.
    Tuteja S; Rader DJ
    Clin Pharmacol Ther; 2014 Jul; 96(1):48-56. PubMed ID: 24713591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability.
    Rosales C; Gillard BK; Xu B; Gotto AM; Pownall HJ
    Methodist Debakey Cardiovasc J; 2019; 15(1):47-54. PubMed ID: 31049149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
    Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
    J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholesterol efflux to high-density lipoproteins and apolipoprotein A-I phosphatidylcholine complexes is inhibited by ethanol: role of apolipoprotein structure and cooperative interaction of phosphatidylcholine and cholesterol.
    Avdulov NA; Chochina SV; Igbavboa U; Wood WG
    Biochemistry; 2000 Aug; 39(34):10599-606. PubMed ID: 10956052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions.
    Van Craeyveld E; Lievens J; Jacobs F; Feng Y; Snoeys J; De Geest B
    Gene Ther; 2009 Jun; 16(6):757-65. PubMed ID: 19242527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alcohol on the major steps of reverse cholesterol transport.
    Serdyuk AP; Metelskaya VA; Ozerova IN; Kovaltchouk NV; Olferiev AM; Bubnova MG; Perova NV; Jauhiainen M; Lasselin C; Castro G
    Biochemistry (Mosc); 2000 Nov; 65(11):1310-5. PubMed ID: 11112849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-density lipoprotein function, dysfunction, and reverse cholesterol transport.
    Fisher EA; Feig JE; Hewing B; Hazen SL; Smith JD
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2813-20. PubMed ID: 23152494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease.
    Besler C; Heinrich K; Riwanto M; Lüscher TF; Landmesser U
    Curr Pharm Des; 2010 May; 16(13):1480-93. PubMed ID: 20196740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein desialylation simultaneously enhances the cell cholesterol uptake and impairs the reverse cholesterol transport system: in vitro evidences utilizing neuraminidase-treated lipoproteins and mouse peritoneal macrophages.
    Harada LM; Carvalho MD; Passarelli M; Quintão EC
    Atherosclerosis; 1998 Jul; 139(1):65-75. PubMed ID: 9699893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
    Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.
    Atger V; de la Llera Moya M; Bamberger M; Francone O; Cosgrove P; Tall A; Walsh A; Moatti N; Rothblat G
    J Clin Invest; 1995 Dec; 96(6):2613-22. PubMed ID: 8675626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects.
    Gille A; Easton R; D'Andrea D; Wright SD; Shear CL
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2106-14. PubMed ID: 24969776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study.
    Curtiss LK; Bonnet DJ; Rye KA
    Biochemistry; 2000 May; 39(19):5712-21. PubMed ID: 10801321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.